Patents by Inventor Lila R. Collins

Lila R. Collins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7897389
    Abstract: This invention provides a new procedure for generating cardiomyocyte lineage cells from embryonic stem cells for use in regenerative medicine. Differentiating by way of embryoid body formation or in serum is no longer required. Instead, the stem cells are plated onto a solid substrate, and differentiated in the presence of select factors and morphogens. After enrichment for cells with the appropriate phenotype, the cells are allowed to cluster into Cardiac Bodies™, which are remarkably homogeneous and suitable for the treatment of heart disease.
    Type: Grant
    Filed: September 15, 2008
    Date of Patent: March 1, 2011
    Assignee: Geron Corporation
    Inventors: Joseph D. Gold, Mohammad Hassanipour, Lila R. Collins, Chunhui Xu
  • Publication number: 20090047739
    Abstract: This invention provides a new procedure for generating cardiomyocyte lineage cells from embryonic stem cells for use in regenerative medicine. Differentiating by way of embryoid body formation or in serum is no longer required. Instead, the stem cells are plated onto a solid substrate, and differentiated in the presence of select factors and morphogens. After enrichment for cells with the appropriate phenotype, the cells are allowed to cluster into Cardiac Bodies™, which are remarkably homogeneous and suitable for the treatment of heart disease.
    Type: Application
    Filed: September 15, 2008
    Publication date: February 19, 2009
    Inventors: Joseph D. Gold, Mohammad Hassanipour, Lila R. Collins, Chunhui Xu
  • Patent number: 7452718
    Abstract: This invention provides a new procedure for generating cardiomyocyte lineage cells from embryonic stem cells for use in regenerative medicine. Differentiating by way of embryoid body formation or in serum is no longer required. Instead, the stem cells are plated onto a solid substrate, and differentiated in the presence of select factors and morphogens. After enrichment for cells with the appropriate phenotype, the cells are allowed to cluster into cardiac bodies™, which are remarkably homogeneous and suitable for the treatment of heart disease.
    Type: Grant
    Filed: March 21, 2005
    Date of Patent: November 18, 2008
    Assignee: Geron Corporation
    Inventors: Joseph D. Gold, Mohammad Hassanipour, Lila R. Collins, Chunhui Xu